CIK: 0001388551 · Show all filings
Period: Q2 2024 (← Previous) (Next →)
Filing Date: Aug 14, 2024
Total Value ($000): $19,731 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XERS | XERIS BIOPHARMA HOLDINGS INC | 5,113,348 | $11,505 | 58.3% | $2.16 | -6.7% | COM | 98422E103 |
| RZLT | REZOLUTE INC | 1,318,967 | $5,672 | 28.7% | $9.52 | -63.9% | COM NEW | 76200L309 |
| SPY | SPDR S&P 500 ETF TR | 1,869 | $1,017 | 5.2% | $488.96 | — | TR UNIT | 78462F103 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 1,025 | $417 | 2.1% | $350.99 | +16.4% | CL B NEW | 084670702 |
| LXEO | LEXEO THERAPEUTICS INC | 17,851 | $286 | 1.5% | $13.31 | +9.1% | COM | 52886X107 |
| — | MIND MEDICINE INC | 30,383 | $219 | 1.1% | $9.30 | — | COM NEW | 60255C885 |
| ABVX | ABIVAX SA | 13,900 | $184 | 0.9% | $10.70 | — | SPONSORED ADS | 00370M103 |
| KYTX | KYVERNA THERAPEUTICS INC | 22,981 | $172 | 0.9% | $23.94 | -36.2% | COM | 501976104 |
| — | MOLECULAR TEMPLATES INC | 136,866 | $157 | 0.8% | $6.32 | — | COM NEW | 608550208 |
| CMPX | COMPASS THERAPEUTICS INC | 43,465 | $43 | 0.2% | $3.23 | -54.8% | COM | 20454B104 |
| CNTX | CONTEXT THERAPEUTICS INC | 18,403 | $37 | 0.2% | $1.72 | 0.0% | COM | 21077P108 |
| — | ADICET BIO INC | 17,488 | $21 | 0.1% | $2.35 | — | COM | 007002108 |